Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: A preliminary report.

被引：0
|
作者：
Vargas, HE [1 ]
Rosati, MJ [1 ]
Douglas, DD [1 ]
Harrison, ME [1 ]
Mulligan, DC [1 ]
Moss, AA [1 ]
Rakela, J [1 ]
Balan, V [1 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
939
引用
收藏
页码：407A / 407A
页数：1
相关论文
共 50 条
  • [21] An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
    Ogawa, Eiichi
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Dohmen, Kazufumi
    Shimoda, Shinji
    Hayashi, Jun
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (05) : 689 - 697
  • [22] Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
    Lin, Ta-Ya
    Yeh, Ming-Lun
    Huang, Ching-I
    Chen, Yao-Li
    Dai, Chia-Yen
    Huang, Jee-Fu
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Chung-Feng
    Yu, Ming-Lung
    Chuang, Wan-Long
    [J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2017, 33 (06): : 284 - 289
  • [23] Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues
    Yu, Ming-Lung
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Chuang, Wan-Long
    [J]. HEPATOLOGY, 2008, 47 (05) : 1792 - 1793
  • [24] Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin
    Asahina, Y.
    Izumi, N.
    Umeda, N.
    Hosokawa, T.
    Ueda, K.
    Doi, F.
    Tsuchiya, K.
    Nakanishi, H.
    Matsunaga, K.
    Kitamura, T.
    Kurosaki, M.
    Uchihara, M.
    Higaki, M.
    Miyake, S.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (06) : 396 - 403
  • [25] Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Gramlich, T
    Liebermann, BY
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 427 - 430
  • [26] Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Egger, H
    Marbet, G
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A382 - A383
  • [27] Short treatment (14 weeks) with pegylated interferon alpha-2b and ribavirin for the treatment of hepatitis C genotype 2/3 infection
    Dalgard, O
    Skaug, K
    Ritland, S
    Myrvang, B
    Hellum, K
    Bjoro, K
    Bell, H
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 134 - 135
  • [28] Treatment of naive hepatitis C recurrence (HCV-R) in liver transplant recipients with pegylated interferon alpha-2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Schiff, E
    Tzakis, A
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 161
  • [29] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Mukherjee, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 727 - 727
  • [30] Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin:: study of sixteen patients
    Rocca, P
    Bailly, FO
    Chevallier, M
    Chevallier, P
    Zoulim, F
    Trépo, C
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (03): : 294 - 299
12345